Barinthus Biotherapeutics (BRNS)
0.99
0.02 (2.06%)
At close: Jan 15, 2025, 2:35 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 802.00K | 44.70M | 268.00K | 4.82M | 6.87M |
| Cost of Revenue | n/a | n/a | n/a | n/a | -0.55 |
| Gross Profit | 802.00K | 44.70M | 268.00K | 4.82M | 6.87M |
| Operating Income | -83.91M | -4.04M | -45.22M | -20.05M | -25.77M |
| Interest Income | 2.88M | 3.10M | 2.00K | 267.06 | 40.37K |
| Pretax Income | -76.52M | 850.00K | -51.14M | -17.84M | -22.79M |
| Net Income | -73.35M | 5.34M | -50.87M | -17.71M | -20.82M |
| Selling & General & Admin | 39.84M | 6.39M | 25.12M | 10.48M | 2.33M |
| Research & Development | 41.41M | 41.11M | 16.37M | 11.11M | 29.97M |
| Other Expenses | 3.46M | 567.00K | 332.00K | 42.00K | 0.00 |
| Operating Expenses | 84.72M | 47.50M | 41.49M | 21.59M | 32.30M |
| Interest Expense | 28.00K | 19.00K | 2.67M | 3.60M | 133.30K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 84.72M | 47.50M | 41.49M | 21.59M | 32.64M |
| Income Tax | -3.17M | -4.47M | -28.00K | 95.00K | -2.02M |
| Shares Outstanding (Basic) | 38.39M | 37.25M | 37.19M | 47.65K | n/a |
| Shares Outstanding (Diluted) | 38.39M | 38.17M | 37.19M | 47.65K | n/a |
| EPS (Basic) | -1.91 | 0.14 | -1.37 | -371.62 | n/a |
| EPS (Diluted) | -1.91 | 0.14 | -1.37 | -371.62 | n/a |
| EBITDA | -71.06M | 6.40M | -47.86M | -14.14M | -22.31M |
| Depreciation & Amortization | 5.45M | 5.54M | 601.93K | 210.02K | 346.86K |